{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:49:20Z","timestamp":1791287360714,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1135,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.bbmt.2011.11.009","type":"journal-article","created":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T19:40:42Z","timestamp":1320954042000},"page":"473-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Patients with Treatment-Related Myelodysplastic Syndrome or Acute Myelogenous\u00a0Leukemia"],"prefix":"10.1016","volume":"18","author":[{"given":"Rachel","family":"Kobos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Steinherz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Kernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Prockop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andromachi","family":"Scaradavou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trudy N.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neerav","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzi","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Boulad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2011.11.009_bib1","series-title":"SEER Cancer Statistics Review, 1975-2005","year":"2008"},{"key":"10.1016\/j.bbmt.2011.11.009_bib2","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","article-title":"Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95","volume":"111","author":"Moricke","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.009_bib3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ejca.2008.02.027","article-title":"Second cancers in patients with the Ewing sarcoma family of tumours","volume":"44","author":"Navid","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bbmt.2011.11.009_bib4","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1200\/JCO.1998.16.9.3016","article-title":"High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors","volume":"16","author":"Kushner","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.11.009_bib5","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1200\/JCO.1998.16.12.3880","article-title":"Neuroblastoma and treatment-related myelodysplasia\/leukemia: the Memorial Sloan-Kettering experience and a literature review","volume":"16","author":"Kushner","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.11.009_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood-2006-01-023101","article-title":"Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: a report from the Children\u2019s Oncology Group","volume":"109","author":"Bhatia","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.009_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/pbc.21931","article-title":"Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma","volume":"53","author":"Kushner","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2011.11.009_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1182\/blood.V100.2.427","article-title":"Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation","volume":"100","author":"Barnard","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.009_bib9","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/cncr.24379","article-title":"Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia","volume":"115","author":"Rizzieri","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2011.11.009_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/pbc.21157","article-title":"Toxicity and outcome of children with treatment related acute myeloid leukemia","volume":"50","author":"Tabori","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2011.11.009_bib11","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1182\/blood-2009-10-249128","article-title":"Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia","volume":"115","author":"Litzow","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.009_bib12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3324\/haematol.2008.000927","article-title":"Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation","volume":"94","author":"Kroger","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2011.11.009_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/MPH.0b013e3181ba43dc","article-title":"Pediatric therapy-related myelodysplastic syndrome\/acute myeloid leukemia: the MD Anderson Cancer Center experience","volume":"31","author":"Aguilera","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.bbmt.2011.11.009_bib14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/pbc.20596","article-title":"Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome","volume":"47","author":"Woodard","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2011.11.009_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mpo.2950100722","article-title":"Sequential high-dose cytosine arabinoside and asparaginase in refractory acute leukemia","volume":"10","author":"Capizzi","year":"1982","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.bbmt.2011.11.009_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/pbc.22321","article-title":"Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia","volume":"54","author":"Steinherz","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2011.11.009_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbmt.2006.10.005","article-title":"Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies","volume":"13","author":"Small","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.11.009_bib18","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1182\/blood-2007-06-093880","article-title":"T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin","volume":"110","author":"Jakubowski","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.009_bib19","series-title":"Bone Marrow and Stem Cell Processing: A Manual of Current Techniques","first-page":"171","article-title":"T cell depletion of bone marrow by treatment with soybean agglutinin and sheep red blood cell rosetting","author":"Collins","year":"1991"},{"key":"10.1016\/j.bbmt.2011.11.009_bib20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","article-title":"IBMTR severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade","volume":"97","author":"Rowlings","year":"1997","journal-title":"Br J of Haematol"},{"key":"10.1016\/j.bbmt.2011.11.009_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","article-title":"Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression","volume":"57","author":"Sullivan","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.009_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cncr.23988","article-title":"Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues","volume":"115","author":"Hijiya","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2011.11.009_bib23","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1200\/JCO.2000.18.9.1845","article-title":"Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a\u00a0report from the Children\u2019s Cancer Group study CCG-2891","volume":"18","author":"Gamis","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.11.009_bib24","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/cncr.24107","article-title":"Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia","volume":"115","author":"Sung","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2011.11.009_bib25","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children\u2019s Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.009_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-0609.2009.01308.x","article-title":"Cytogenetics of pediatric acute myeloid leukemia","volume":"83","author":"Manola","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2011.11.009_bib27","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1200\/JCO.2009.25.6321","article-title":"Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98","volume":"28","author":"von Neuhoff","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.11.009_bib28","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood.V91.3.1083","article-title":"T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease","volume":"91","author":"Papadopoulos","year":"1998","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879111004782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879111004782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:41:03Z","timestamp":1761057663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879111004782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1083879111004782"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.11.009","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Patients with Treatment-Related Myelodysplastic Syndrome or Acute Myelogenous\u00a0Leukemia","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}